Video
22 Oct 2021
About IDT Biologika
Content provided by our supplier
IDT Biologika GmbH
-
DE -
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
Other Content from IDT Biologika GmbH (4)
-
News Are you looking for Drug Substance, Fill&Finish and Packaging capacities?
We are very proud to extend our facilities in Drug Substance according to BSL 3 and to set up another high-speed filling capacities. Due to our great know-how, commercial excellence, strong partnerships and customer centricity we will push both, innovation and new production capacities for important vaccines against infectious diseases affecting people worldwide. -
Brochure IDT Biologika Services
Contract Development and Manufacturing of Vaccines, Viral Vectors for Gene & Immune Therapeutics and Oncolytic Viruses, Virus-like Particles -
News AstraZeneca partners with IDT Biologika to build COVID-19 vaccine facility in Germany
Firms plan to invest in capacity expansion at the CDMO’s manufacturing site in Dessau to boost European domestic vaccine supply -
Brochure About IDT Biologika Services
About IDT Biologika Services
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance